| Schedule of Related Party Transactions |
The following tables summarize the Company’s transactions with Atrio:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2024 |
|
2023 |
|
(in thousands) |
| Capitated revenue |
$ |
303,606 |
|
|
$ |
192,577 |
|
| Other patient service revenue |
$ |
4,340 |
|
|
$ |
2,737 |
|
| Medical expense |
$ |
345,566 |
|
|
$ |
197,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2024 |
|
2023 |
|
(in thousands) |
| Health plan receivable |
$ |
23,872 |
|
|
$ |
5,290 |
|
| Claims payable |
$ |
61,090 |
|
|
$ |
41,348 |
|
| Health plan settlements payable |
$ |
1,386 |
|
|
$ |
4,176 |
|
Deferred revenue (1)
|
$ |
— |
|
|
$ |
12,700 |
|
__________________
(1)Amount is included within accrued expenses and other current liabilities on the Company’s consolidated balance sheet.
The following tables summarize the Company’s transactions with VGS, VGS 2, and VGS 3:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2024 |
|
2023 |
|
(in thousands) |
| Interest expense, net |
$ |
9,025 |
|
|
$ |
3,905 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2024 |
|
2023 |
|
(in thousands) |
| Long-term debt, net |
$ |
74,823 |
|
|
$ |
28,319 |
|
| Accrued interest |
$ |
3,992 |
|
|
$ |
4,010 |
|
| Accrued expenses |
$ |
437 |
|
|
$ |
331 |
|
|